AxoGen, Inc.
AXGN
$14.81
-$1.45-8.92%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 17.17% | 18.81% | 17.81% | 18.79% | 17.26% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 17.17% | 18.81% | 17.81% | 18.79% | 17.26% |
Cost of Revenue | 25.16% | 33.13% | 22.13% | 37.21% | 44.15% |
Gross Profit | 14.64% | 14.52% | 16.50% | 13.81% | 10.71% |
SG&A Expenses | 5.73% | 1.70% | 1.30% | -0.08% | -0.31% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.55% | 6.85% | 5.63% | 7.51% | 7.55% |
Operating Income | 114.02% | 97.92% | 84.68% | 64.41% | 50.59% |
Income Before Tax | 71.80% | 66.33% | 54.12% | 38.43% | 29.53% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 71.80% | 66.33% | 54.12% | 38.43% | 29.53% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 71.80% | 66.33% | 54.12% | 38.43% | 29.53% |
EBIT | 114.02% | 97.92% | 84.68% | 64.41% | 50.59% |
EBITDA | 242.94% | 148.99% | 120.31% | 90.89% | 71.87% |
EPS Basic | 72.70% | 67.43% | 54.69% | 39.39% | 30.64% |
Normalized Basic EPS | 72.71% | 67.40% | 54.69% | 39.37% | 30.62% |
EPS Diluted | 72.38% | 68.05% | 55.86% | 41.09% | 31.07% |
Normalized Diluted EPS | 72.38% | 67.27% | 54.56% | 39.37% | 30.62% |
Average Basic Shares Outstanding | 4.05% | 3.20% | 2.45% | 1.82% | 1.80% |
Average Diluted Shares Outstanding | 7.00% | 5.05% | 4.31% | 1.82% | 1.80% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |